Back to search
Ischemic Stroke, Cryptogenic
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Ischemic Stroke, Cryptogenic trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Ischemic Stroke, Cryptogenic trials you may qualify forPatent foramen ovale PFO closure has been shown to reduce the risk of stroke in patients with recurrent stroke. However, the majority of existing clinical studi…
To assess whether PFO closure plus antiplatelet therapy is superior to antiplatelet therapy alone and whether oral anticoagulant therapy is superior to antiplat…
To determine the safety of antithrombotic treatment discontinuation 12 months following successful transcatheter PFO closure.
The goal of this clinical trial is to test a new heart device called P3 Occluder System in patients who have a small opening between the upper chambers of the h…
This study will test the sensitivity of a novel, battery-powered, non-invasive ultrasound device to detect a right-to-left shunt
The goal of this clinical trial is to learn how well the SONAS ultrasound device can detect right-to-left shunts of adults with hereditary hemorrhagic telangiec…
This study is a prospective, multicenter, randomized, controlled, single-blind, investigator-driven, non-profit clinical trial designed to compare the safety an…
This is a multi-center, randomized, double-blind, placebo-controlled trial of MLC1501 in patients with stroke. Eligible participants will be randomized in a 1:1…
The investigator retrospectively analyzed consecutive young (\<60 years) cryptogenic stroke patients with Patient Foramen Ovale (PFO) recruited between January…